Target species
Dogs, cats and horses.
Indications for use
Treatment of keratitis, conjunctivitis and blepharitis caused by Staphylococcus spp., Streptococcus spp., Proteus spp. and/or Pseudomonas spp.
Contraindications
Do not use in cases of hypersensitivity to the active substance, to other tetracyclines or to any of the excipients.
Special precautions for use in animals
Use of the veterinary medicinal product should be based on identification and susceptibility testing of the target pathogen(s). If this is not possible, therapy should be based on epidemiological information and knowledge of susceptibility of the target pathogens at farm level, or at local/regional level.
Use of the product should be in accordance with official, national and regional antimicrobial policies.
Use of the veterinary medicinal product deviating from the instructions given in this datasheet may increase the prevalence of bacteria resistant to chlortetracycline and may decrease the effectiveness of treatment with other tetracyclines due to the potential for cross-resistance.
Special precautions to be taken by the person administering the veterinary medicinal product to animals
This veterinary medicinal product may cause skin sensitisation, hypersensitivity reactions and/or eye irritation.
People with a known hypersensitivity to tetracyclines should avoid contact with the veterinary medicinal product.
Avoid contact with the skin and eyes.
Wear impermeable gloves when handling the product.
In case of contact with the skin, wash exposed skin with water and soap. If you develop symptoms following exposure such as a skin rash, seek medical advice immediately and show the package leaflet or label to the physician.
In case of contact with the eyes, wash immediately with clean water. If irritation persists, seek medical advice immediately and show the package leaflet or label to the physician.
Wash hands after use.
Adverse reactions
Application site reactions and eye disorders like irritation, pruritus, oedema and reddening have been very rarely reported after administration of the veterinary medicinal product in isolated cases in spontaneous reports.
The frequency of adverse reactions is defined using the following convention:
- very common (more than 1 in 10 animals treated displaying adverse reaction(s))
- common (more than 1 but less than 10 animals in 100 animals treated)
- uncommon (more than 1 but less than 10 animals in 1,000 animals treated)
- rare (more than 1 but less than 10 animals in 10,000 animals treated)
- very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
Use during pregnancy and lactation
The safety of the veterinary medicinal product has not been established during pregnancy and lactation. Use only according to the benefit/risk assessment by the responsible veterinarian.
Amounts to be administered and administration route
For ocular use only.
Horses: Apply 2-3 cm of ointment (depending on the size of the animal) in the conjunctival sac 4 times a day for 5 days. If after 3 days of treatment no clinical improvement has occurred, alternative therapy should be considered.
Dogs and cats: Apply 0.5-2 cm of ointment (depending on the size of the animal) in the conjunctival sac 4 times a day for 5 days. If after 3 days of treatment no clinical improvement has occurred, alternative therapy should be considered.
Withdrawal periods
Meat and offal: 1 day
Not authorised for use in horses producing milk intended for human consumption.